|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.790 USD | -2.16% |
|
-2.16% | +2.11% |
| 06-22 | Evolus, Inc.(NasdaqGM:EOLS) added to S&P Pharmaceuticals Select Industry Index | CI |
| 05-11 | Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe | CI |
| Market Cap | 457M 400M 369M 341M 648M 43.67B 659M 4.43B 1.72B 21.41B 1.72B 1.68B 74.31B | P/E 2026 * |
-14x | P/E 2027 * | -47.3x |
|---|---|---|---|---|---|
| Enterprise Value | 584M 512M 472M 436M 828M 55.8B 843M 5.66B 2.2B 27.36B 2.19B 2.15B 94.96B | EV / Sales 2026 * |
1.77x | EV / Sales 2027 * | 1.52x |
| Free-Float |
83.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evolus, Inc.
| 1 day | -2.16% | ||
| 1 week | -2.16% | ||
| Current month | -2.16% | ||
| 1 month | +1.80% | ||
| 3 months | +66.42% | ||
| 6 months | +19.96% | ||
| Current year | +2.11% |
| 1 week | 6.7 |  | 7.24 |
| 1 month | 6.42 | | 7.32 |
| Current year | 3.86 | | 7.32 |
| 1 year | 3.86 | | 10.2 |
| 3 years | 3.86 | | 17.82 |
| 5 years | 3.86 | | 17.82 |
| 10 years | 2.85 | | 39.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Moatazedi
CEO | Chief Executive Officer | 48 | 05/05/2018 |
Tatjana Mitchell
DFI | Director of Finance/CFO | 48 | 07/09/2025 |
Jon Yerbury
COO | Chief Operating Officer | - | 31/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
David Gill
BRD | Director/Board Member | 71 | 11/02/2018 |
Albert White
BRD | Director/Board Member | 56 | 30/06/2024 |
Vikram Malik
CHM | Chairman | 63 | 31/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-19 | Sell | Chief Executive Officer | 13,669 | 0.0211% | ||
| 03-19 | Sell | Chief Technology Officer | 3,119 | 0.0048% | ||
| 03-15 | Fiscal year | Chief Technology Officer | 47,604 | 0.0736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | -2.16% | -25.71% | -5.03% | 457M | |
| -1.60% | +1.37% | +57.31% | +168.94% | 1,102B | |
| -1.44% | +3.71% | +69.64% | +65.40% | 643B | |
| -0.75% | +0.44% | +34.70% | +86.52% | 450B | |
| -1.35% | +0.63% | +30.26% | +26.28% | 336B | |
| -0.86% | +0.99% | +39.36% | +40.85% | 298B | |
| -0.71% | -0.54% | +28.98% | +48.27% | 288B | |
| -1.31% | +2.72% | -26.76% | -39.82% | 222B | |
| -0.03% | +1.62% | +25.62% | +68.30% | 199B | |
| -0.40% | +7.50% | +21.51% | +82.50% | 169B | |
| Average | -0.94% | +2.22% | +25.49% | +54.22% | 370.64B | |
| Weighted average by Cap. | -0.50% | +2.14% | +42.24% | +86.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 330M 289M 267M 247M 468M 31.57B 477M 3.2B 1.25B 15.48B 1.24B 1.21B 53.73B | 388M 340M 313M 290M 549M 37.04B 559M 3.76B 1.46B 18.16B 1.46B 1.42B 63.03B |
| Net income | -33.31M -29.17M -26.92M -24.87M -47.2M -3.18B -48.06M -323M -126M -1.56B -125M -122M -5.42B | -10.56M -9.25M -8.54M -7.89M -14.97M -1.01B -15.24M -102M -39.81M -495M -39.66M -38.79M -1.72B |
| Net Debt | 127M 111M 103M 94.84M 180M 12.13B 183M 1.23B 479M 5.95B 477M 466M 20.65B | 132M 116M 107M 98.58M 187M 12.61B 190M 1.28B 498M 6.18B 496M 485M 21.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | US$6.790 | -2.16% | 1,279,838 |
| 07/07/26 | US$6.940 | -0.72% | 705,989 |
| 06/07/26 | US$6.990 | +1.30% | 643,642 |
| 02/07/26 | US$6.900 | +2.37% | 534,868 |
| 01/07/26 | US$6.740 | -2.88% | 567,581 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EOLS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
